Anjie Medical has released its 2026 semi-annual report, with attributable net profit for the first half reaching approximately 118 million yuan, a year-on-year decline of 6.27%. Operating revenue for the same period was about 302 million yuan, down 0.28% year-on-year. The company's main business revenue was approximately 297 million yuan, a year-on-year decrease of 0.97%, of which domestic market sales revenue was about 95.7881 million yuan, down 30.32% year-on-year, and overseas market sales revenue was about 201 million yuan, up 23.81% year-on-year. Anjie Medical is engaged in the research, development, production and sales of minimally invasive endoscopic diagnosis and treatment devices, with its main products applied in the field of digestive endoscopy.
Hangzhou AGS MedTech Co. Ltd. AFirst-half net profit fell 6.27% year-on-year, with domestic sales down 30.32%.
